INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Institutua
Universidad de Navarra
Pamplona, EspañaUniversidad de Navarra-ko ikertzaileekin lankidetzan egindako argitalpenak (9)
2023
-
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91
2022
-
Mitochondrial Oxidative Stress Induces Cardiac Fibrosis in Obese Rats through Modulation of Transthyretin
International journal of molecular sciences, Vol. 23, Núm. 15
2021
-
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality
Journal of Clinical Investigation, Vol. 131, Núm. 23
-
Long-term efficacy of autologous bone marrow mesenchymal stromal cells for treatment of knee osteoarthritis
Journal of Translational Medicine
2020
-
Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research
Cytotherapy, Vol. 22, Núm. 1, pp. 1-5
2018
-
Novel clinical and molecular findings in Spanish patients with naevoid basal cell carcinoma syndrome
British Journal of Dermatology, Vol. 178, Núm. 1, pp. 198-206
2014
-
Classification of current anticancer immunotherapies
Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508
2010
-
Mitochondria and calcium flux as targets of neuroprotection caused by minocycline in cerebellar granule cells
Biochemical Pharmacology, Vol. 79, Núm. 2, pp. 239-250
2006
-
Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS
International Immunology, Vol. 18, Núm. 5, pp. 785-795